ArticleRespiratory research2026
Epoxyeicosatrienoic acids protect airway epithelial mitochondria by activating the cAMP/PKA-DRP1 Ser637 axis in cigarette smoke-induced lung injury.
Article in Respiratory research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundCigarette smoke–induced airway epithelial injury is a central pathological feature of chronic obstructive pulmonary disease (COPD) and is closely associated with mitochondrial dysfunction. Excessive dynamin-related protein 1 (DRP1)–mediated mitochondrial fission contributes to epithelial oxidative stress and apoptosis; however, the endogenous regulatory mechanisms limiting aberrant DRP1 activation in the airway epithelium remain poorly understood. Epoxyeicosatrienoic acids (EETs), lipid mediators metabolized by soluble epoxide hydrolase (EPHX2), have been implicated in lung protection, but their role in regulating mitochondrial dynamics in cigarette smoke–exposed airway epithelium has not been established.
methodsWild-type and EPHX2-/- mice were exposed to chronic cigarette smoke to evaluate mitochondrial morphology, oxidative stress, epithelial apoptosis, and lung mechanics. In vitro, BEAS-2B airway epithelial cells were exposed to cigarette smoke extract (CSE) with pharmacological or genetic modulation of EET signaling. Mitochondrial structure and function, including reactive oxygen species production, mitochondrial membrane potential, and DRP1 phosphorylation status, were assessed using confocal microscopy, transmission electron microscopy, and immunoblotting.
resultsChronic cigarette smoke exposure induced marked mitochondrial fragmentation, increased oxidative stress, and epithelial apoptosis, accompanied by enhanced DRP1 activation. Genetic deletion of EPHX2 or exogenous EET supplementation preserved mitochondrial network integrity and significantly attenuated DRP1-mediated mitochondrial fission in both in vivo and in vitro models. In vivo, restoration of inhibitory DRP1 Ser637 phosphorylation was associated with reduced mitochondrial fragmentation, whereas in vitro EETs promoted inhibitory DRP1 Ser637 phosphorylation via activation of the cAMP/PKA signaling pathway, thereby limiting pathological mitochondrial fission and mitigating epithelial cell injury.
conclusionsEETs act as endogenous modulators of mitochondrial dynamics in airway epithelial cells. By restraining DRP1-mediated mitochondrial fission, EET signaling protects against cigarette smoke–induced mitochondrial dysfunction and epithelial injury, supporting the EPHX2–EET axis as a mechanistically and clinically relevant pathway for further translational investigation in COPD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.